Clinical Trials Logo

Clinical Trial Summary

For spontaneous breathing patients with tracheostomy, whose lower airway is directly opened to the room air, the aerosol particles generated by the patients would be directly dispersed into the room air, which might be an direct resource of virus transmission. However, the transmission risk has not been evaluated and the appropriate humidification therapy is unknown. Thus this study is aimed to investigate the aerosol particle concentrations among different oxygen devices for spontaneous breathing patients with tracheostomy, in order to reflect the transmission risk.


Clinical Trial Description

The transmission route of the SARS-CoV-2 virus remains controversial, and concerns persist of potentially increased virus transmission when utilizing high-flow devices and aerosol devices among COVID-19 patients. For spontaneous breathing patients with tracheostomy, whose lower airway is directly opened to the room air, the aerosol particles generated by the patients would be directly dispersed into the room air, which might be an direct resource of virus transmission. However, the transmission risk of tracheostomy during spontaneous breathing has not been evaluated and the appropriate humidification therapy is unknown. Thus this study is aimed to investigate the aerosol particle concentrations among different oxygen devices for spontaneous breathing patients with tracheostomy, in order to reflect the transmission risk. ;


Study Design


Related Conditions & MeSH terms

  • Transmission, Patient-Professional

NCT number NCT04654754
Study type Interventional
Source Rush University Medical Center
Contact
Status Completed
Phase N/A
Start date December 23, 2020
Completion date July 16, 2021

See also
  Status Clinical Trial Phase
Completed NCT04681599 - Different Modalities in Reducing Airborne Particulate Concentrations During AGP for Health Volunteers N/A
Terminated NCT04526925 - The Effects of Filter During CPET on WOB and Aerosol Particle Concentrations N/A